Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1974 2
1975 2
1976 2
1977 1
1979 3
1980 1
1982 4
1983 2
1985 1
1986 2
1987 2
1989 5
1990 2
1991 1
1992 4
1993 5
1994 4
1995 2
1996 2
1997 2
1998 3
1999 2
2000 1
2001 3
2002 3
2003 1
2004 5
2005 4
2006 5
2007 5
2008 8
2009 8
2010 10
2011 16
2012 18
2013 26
2014 20
2015 14
2016 19
2017 25
2018 20
2019 12
2020 21
2021 19
2022 24
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Results by year

Filters applied: . Clear all
Page 1
Dual diagnosis in Depression: treatment recommendations.
Tirado Muñoz J, Farré A, Mestre-Pintó J, Szerman N, Torrens M. Tirado Muñoz J, et al. Among authors: torrens m. Adicciones. 2018 Jan 1;30(1):66-76. doi: 10.20882/adicciones.868. Adicciones. 2018. PMID: 28492960 Free article. Review. English, Spanish.
MDMA interactions with pharmaceuticals and drugs of abuse.
Papaseit E, Pérez-Mañá C, Torrens M, Farré A, Poyatos L, Hladun O, Sanvisens A, Muga R, Farré M. Papaseit E, et al. Among authors: torrens m. Expert Opin Drug Metab Toxicol. 2020 May;16(5):357-369. doi: 10.1080/17425255.2020.1749262. Epub 2020 Apr 12. Expert Opin Drug Metab Toxicol. 2020. PMID: 32228243 Review.
Clinical practice guideline on pharmacological and psychological management of adult patients with an anxiety disorder and comorbid substance use.
Sáiz PA, Flórez G, Arrojo M, Bernardo M, González-Pinto A, Goikolea JM, Zorrilla I, Cunill R, Castells X, Becoña E, López A, Torrens M, Fonseca F, Tirado-Muñoz J, Arranz B, Garriga M, San L. Sáiz PA, et al. Among authors: torrens m. Adicciones. 2022 Apr 1;34(2):157-167. doi: 10.20882/adicciones.1548. Adicciones. 2022. PMID: 34171105 Free article. Review. English, Spanish.
Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use.
Cunill R, Castells X, González-Pinto A, Arrojo M, Bernardo M, Sáiz PA, Flórez G, Torrens M, Tirado-Muñoz J, Fonseca F, Arranz B, Garriga M, Goikolea JM, Zorrilla I, Becoña E, López A, San L. Cunill R, et al. Among authors: torrens m. Adicciones. 2022 Apr 1;34(2):168-178. doi: 10.20882/adicciones.1569. Adicciones. 2022. PMID: 34171106 Free article. Review. English, Spanish.
Dual diagnosis: an European perspective.
Torrens M, Mestre-Pintó JI, Montanari L, Vicente J, Domingo-Salvany A. Torrens M, et al. Adicciones. 2017 Jan 1;29(1):3-5. doi: 10.20882/adicciones.933. Adicciones. 2017. PMID: 28170050 Free article. Review. English, Spanish.
Pharmacogenetics of Methadone Response.
Fonseca F, Torrens M. Fonseca F, et al. Among authors: torrens m. Mol Diagn Ther. 2018 Feb;22(1):57-78. doi: 10.1007/s40291-017-0311-y. Mol Diagn Ther. 2018. PMID: 29168075 Review.
Cannabinoids: from pot to lab.
Papaseit E, Pérez-Mañá C, Pérez-Acevedo AP, Hladun O, Torres-Moreno MC, Muga R, Torrens M, Farré M. Papaseit E, et al. Among authors: torrens m. Int J Med Sci. 2018 Aug 6;15(12):1286-1295. doi: 10.7150/ijms.27087. eCollection 2018. Int J Med Sci. 2018. PMID: 30275754 Free PMC article. Review.
Comprehensive interventions for reducing cannabis use.
Tirado-Muñoz J, Mestre-Pintó JI, Farré M, Fonseca F, Torrens M. Tirado-Muñoz J, et al. Among authors: torrens m. Curr Opin Psychiatry. 2018 Jul;31(4):315-323. doi: 10.1097/YCO.0000000000000430. Curr Opin Psychiatry. 2018. PMID: 29746419 Review.
321 results